Wisdom News & Insights

Wisdom News brings you analysis of notable decisions from courts, legal reforms and updates in East Asia (Taiwan, China, Japan and Hong Kong etc). Please leave your email address here to subscribe to our newsletter and stay updated on the latest IP developments.

2025-12-15 China’s Revised Examination Guidelines Take Aim at Non-Contributory Features in Inventive Step Assessment (Effective 01/01/2026)
Patents
2025-09-04 CNIPA Sets Out When Parameter Features Qualify as Distinguishing Features
Patents
2025-05-19 Claim Construction: Indobufen Crystal Patent Survives Multiple Invalidation Challenges Before CNIPA
Patents
2024-11-14 Court Ruling on Patent Claim Interpretation
Patents
2024-10-18 Pharmaceutical Patents: The Judicial Practice of the Supreme People's Court of China Regarding Supplementary Experimental Data
Patents
2024-09-20 The Court Overturns CNIPA’s Determination on the Written Description Requirement for Parameter Limits
Patents
2024-08-08 The Supreme People's Court of China’s Decision on the Requirements for Parameter Claims
Patents
2024-01-19 Invalidation of Compound “Upadacitinib” by CNIPA - Admissibility of Supplementary Experimental Data in China
Patents
2023-09-28 Amendment to Markush Claim in China and Takeaways
Patents
2023-08-17 The Taiwan FTC Imposed Fines on Companies Advertising Products Marked with Revoked Patent Numbers
Patents
2023-07-13 Trends on Recent Judgment of Parameter Claims in China
Patents
2023-03-09 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part IV
Patents
2023-02-24 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part III
Patents
2023-02-01 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part II
Patents
2023-01-13 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part I
Patents
2023-01-04 When are Trademarks Deceptive? Comparing Food and Drug Trademarks in Taiwan and China
Trademarks
2022-12-02 PART II— Five Patent Invalidation Challenges- CSPC Succeeded in invalidating Mitsubishi Tanabe Pharma Corporation’s Novastan® HI injection 10 mg/2mL Patent
Patents
2022-10-25 PART I— Five Patent Invalidation Challenges- CSPC Succeeded in invalidating Mitsubishi Tanabe Pharma Corporation’s Novastan® HI injection 10 mg/2mL Patent
Patents
2022-08-31 Latest Judgement on Inventive Step of Semiconductor Patent: Dow Global Technologies and Rohm and Haas’s Equipment Patent Was Declared Invalid
Patents
2022-07-28 Top 10 Patent Cases of 2021 - Actelion’s OPSUMIT® Pharma Patent Survived the Invalidation
Patents
Cart

Login

Login Success